Literature DB >> 11714442

Anticarcinogenic effect and enhancement of metastatic potential of BALB/c 3T3 cells by ginsenoside Rh(2).

M Tatsuka1, M Maeda, T Ota.   

Abstract

It has been reported that ginsenoside Rh(2), a purified ginseng saponin with a dammarane skeleton, has anticarcinogenic effects on mammalian cells. To determine the significance of these effects on multistage carcinogenesis, we utilized the BALB / c 3T3 cell system. In an in vitro two-stage neoplastic transformation assay, the initiating activity of 3-methylcholanthrene (3-MCA) was suppressed by Rh(2) (>or= 1 x 10(-5) M) in both BALB / c 3T3 A31-1-1 cells and the more carcinogen-susceptible variant A31-1-13 cells. The suppressive effects in this concentration range were thought to be caused by suppression of DNA replication via indirect Cdk2 inhibition. On the other hand, the promotion steps of both the target cells were not affected by Rh(2) even if the transformation frequency was enhanced by a tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA). To examine the other effects of Rh(2) on carcinogenesis, we turned our attention to the metastatic phenotype. Using metastatic src-transformed A31-1-1 cells, we found that Rh(2) augmented the metastatic potential in an experimental metastasis assay. These data indicate that Rh(2) has diverse effects on the expression of the transformed phenotype in BALB / c 3T3 cells, but support the idea that growth suppression is likely to be a major mechanism of the anticarcinogenic effects of Rh(2).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11714442      PMCID: PMC5926664          DOI: 10.1111/j.1349-7006.2001.tb02138.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  35 in total

1.  The role of cell division in the malignant transformation of mouse cells treated with 3-methylcholanthrene.

Authors:  T Kakunaga
Journal:  Cancer Res       Date:  1975-07       Impact factor: 12.701

2.  Involvement of cyclin-dependent kinases in doxorubicin-induced apoptosis in human tumor cells.

Authors:  Y Lu; M Tatsuka; H Takebe; T Yagi
Journal:  Mol Carcinog       Date:  2000-09       Impact factor: 4.784

3.  Induction of phenotypic reverse transformation by ginsenosides in cultured Morris hepatoma cells.

Authors:  S Odashima; Y Nakayabu; N Honjo; H Abe; S Arichi
Journal:  Eur J Cancer       Date:  1979-06       Impact factor: 9.162

4.  Involvement of peanut agglutinin-binding sugar chains in experimental metastasis of B16 melanoma cells.

Authors:  T Ota; H Kohno; M Maeda; M Tanino; S Odashima
Journal:  Oncol Res       Date:  1993       Impact factor: 5.574

5.  Differential expression of protein kinase C subtypes during ginsenoside Rh2-lnduced apoptosis in SK-N-BE(2) and C6Bu-1 cells.

Authors:  Y S Kim; S H Jin; Y H Lee; J D Park; S I Kim
Journal:  Arch Pharm Res       Date:  2000-10       Impact factor: 4.946

6.  G1 phase-specific suppression of the Cdk2 activity by ginsenoside Rh2 in cultured murine cells.

Authors:  T Ota; M Maeda; S Odashima; J Ninomiya-Tsuji; M Tatsuka
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

7.  Different metastatic potentials of ras- and src-transformed BALB/c 3T3 A31 variant cells.

Authors:  M Tatsuka; T Ota; N Yamagishi; Y Kashihara; M Wada; N Matsuda; H Mitsui; M Seiki; S Odashima
Journal:  Mol Carcinog       Date:  1996-04       Impact factor: 4.784

8.  Effect of Panax ginseng saponins and Eleutherococcus senticosus on survival of cultured mammalian cells after ionizing radiation.

Authors:  E Ben-Hur; S Fulder
Journal:  Am J Chin Med       Date:  1981       Impact factor: 4.667

9.  D-type cyclin-dependent kinase activity in mammalian cells.

Authors:  H Matsushime; D E Quelle; S A Shurtleff; M Shibuya; C J Sherr; J Y Kato
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

10.  Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells.

Authors:  H Nakata; Y Kikuchi; T Tode; J Hirata; T Kita; K Ishii; K Kudoh; I Nagata; N Shinomiya
Journal:  Jpn J Cancer Res       Date:  1998-07
View more
  5 in total

1.  RhoGDIbeta lacking the N-terminal regulatory domain suppresses metastasis by promoting anoikis in v-src-transformed cells.

Authors:  Takahide Ota; Masayo Maeda; Shiho Sakita-Suto; Xinwen Zhou; Manabu Murakami; Tsutomu Takegami; Masaaki Tatsuka
Journal:  Clin Exp Metastasis       Date:  2006-11-17       Impact factor: 5.150

2.  Development of a HPLC-MS assay for ginsenoside Rh2, a new anti-tumor substance from natural product and its pharacokinetic study in dogs.

Authors:  Hai-Tang Xie; Guang-Ji Wang; Hua Lv; Rui Wang Jian-Guo Sun; Xi-Ling Jiang; Hao Li; Wei Wang; Chen-Rong Huang; Mei-Juan Xu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jan-Jun       Impact factor: 2.441

3.  Changes of [3H]MK-801, [3H]muscimol and [3H]flunitrazepam binding in rat brain by the prolonged ventricular infusion of transformed ginsenosides.

Authors:  Soyong Jang; Jong Hoon Ryu; Dong-Hyun Kim; Seikwan Oh
Journal:  Neurochem Res       Date:  2004-12       Impact factor: 3.996

4.  The Yin and Yang actions of North American ginseng root in modulating the immune function of macrophages.

Authors:  Chike Godwin Azike; Paul Abrahams Charpentier; Jirui Hou; Hua Pei; Edmund Man King Lui
Journal:  Chin Med       Date:  2011-05-27       Impact factor: 5.455

Review 5.  Gut microbiota-mediated pharmacokinetics of ginseng saponins.

Authors:  Dong-Hyun Kim
Journal:  J Ginseng Res       Date:  2017-04-28       Impact factor: 6.060

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.